Recent News and Insights

ASX slips as Trump tariffs spark trade war fears; Cochlear gains FDA approval, Platinum faces $428m fund outflows.

Wall Street rallies on strong US jobs data and trade deals. ASX steady as Santos, Qantas, and Air New Zealand headline key market developments.

Interest rate cuts are back on the agenda in Australia, and savvy investors are repositioning fast. Discover why falling inflation, Trump’s stimulus bill, and global market trends could reshape your portfolio—and which 3 ASX stocks we think are best positioned for the weeks ahead

Wall Street hit record highs on trade optimism and steady inflation, while the ASX dipped with Financials and Healthcare lagging. DroneShield (ASX: DRO) surged on a $9.7m contract. Nike (NYSE: NKE) rallied after shifting production to the U.S.

US markets held steady as a Trump-brokered Israel-Iran ceasefire eased geopolitical tensions. Fed Chair Powell signalled no immediate rate cuts. Earnings were mixed, with Nvidia surging, while BP, FedEx, and Aurizon dipped. APA gained regulatory approval on Basslink. ASX 200 closed slightly higher, led by Financials and Utilities.

US stocks rally as Iran tensions ease and rate cut signals emerge. Brent crude plunges. ASX 200 slips. APA lifts dividend forecast; Collins Foods profit drops. Read the latest market summary from Australian Stock Report.

Markets are rattled after the US strikes Iran, oil prices are climbing, and investors are bracing for volatility. Here's how it could impact the ASX and where smart money is moving.

Global equity markets softened late last week as a wave of geopolitical and macroeconomic uncertainty weighed on investor sentiment. In the US, the S&P 500 slipped 0.3% on Friday

Australian shares slipped on Thursday, while global investors weighed rising oil prices, geopolitical tensions, and economic warnings from Russia